FGF21 and obesity due to melanocortin 4 receptor deficiency: FGF21 expression is elevated in both obese humans and mice [71], and the exogenous administration of FGF21 has been shown to mitigate obesity by reducing inflammation, promoting the browning of white adipose tissue, and enhancing heat production [72,73].